Skip to content
Open access

Secreted nuclease effector neutralization by active site mimicry in Bacillota

Aug 2026 · mBio · Vol 17 · 0 citations · 37 references
Medicine

TL;DR

A multivalent Tde/Tdi neutralization mechanism where an initial high-affinity interface increases the local concentration of Tdi’s P(Φ)4GG motif, enabling it to displace the Tde active site through structural mimicry, which may aid in eliminating the toxic effector.

Abstract

ABSTRACT Polymorphic toxins mediate interbacterial antagonism among competitors in the gut microbiome. Nuclease effectors, distantly related to the type VI-secreted Bacteroidales Tde, are enriched in human gut Bacillota. Tde mediates antagonism among Bacillota, and expression of the cognate immunity, Tdi, in recipients is protective. Crystal structures of Tde/Tdi complexes from two Bacillus spp. and Enterococcus quebecensis highlight a conserved mechanism of immunity. Tdi engages Tde with high-affinity, specific binding at an interface that features predominantly polar amino acids. A separate Tdi interface has a very highly conserved P(Φ)4GG motif that structurally mimics and displaces a short helix in Tde’s active site, which contains the critical catalytic residues. An isolated P(Φ)4GG motif peptide is sufficient for Tde nuclease activity inhibition at high concentrations. However, key residues at both the polar interface and P(Φ)4GG are required for complete inhibition of nuclease activity and protection against toxicity. We propose a multivalent Tde/Tdi neutralization mechanism where an initial high-affinity interface increases the local concentration of Tdi’s P(Φ)4GG motif, enabling it to displace the Tde active site through structural mimicry. The resulting conformational rearrangement of Tde increases its flexibility in solution and susceptibility to proteolysis, which may aid in eliminating the toxic effector. IMPORTANCE Bacteria in the gut microbiome compete using toxin secretion systems. Prior research has emphasized the importance of secretion systems in gram-negative bacteria. We describe a class of secreted nuclease effectors (toxins) and protective immunity proteins that are enriched in gram-positive Bacillota in human gut microbiomes. These effector/immunity pairs mediate antagonism among Bacillus and Enterococcus spp. The immunity proteins neutralize the nuclease effector through a unique mechanism of enzymatic active site mimicry. The immunity proteins bind effectors with very high-affinity at an interface with polar residues. The effector undergoes a large conformational change. A very highly conserved motif on the immunity surface competitively displaces an active site short helix and loop that contains the key catalytic residues. This rearrangement of the effector renders it inactive and susceptible to elimination by proteolysis. Bacteria in the gut microbiome compete using toxin secretion systems. Prior research has emphasized the importance of secretion systems in gram-negative bacteria. We describe a class of secreted nuclease effectors (toxins) and protective immunity proteins that are enriched in gram-positive Bacillota in human gut microbiomes. These effector/immunity pairs mediate antagonism among Bacillus and Enterococcus spp. The immunity proteins neutralize the nuclease effector through a unique mechanism of enzymatic active site mimicry. The immunity proteins bind effectors with very high-affinity at an interface with polar residues. The effector undergoes a large conformational change. A very highly conserved motif on the immunity surface competitively displaces an active site short helix and loop that contains the key catalytic residues. This rearrangement of the effector renders it inactive and susceptible to elimination by proteolysis.

Read PDF

Similar papers

Open access Sep 2026

A widespread bacterial toxin reveals a deeply divergent DNase family neutralized by diverse immunity proteins

Bacteria compete for space and resources by delivering toxin proteins into neighboring cells. Many toxins remain uncharacterized because they lack similarity to proteins of known function. Here we identify Rehh as a widespread antibacterial toxin associated with multiple bacterial secretion systems and show that it is...

Audrey R. Long, G. Simpson, J. T. Hespanhol et al. · 0 citations
#protein folding Open access Sep 2026

Molecular characterization of the orphan toxin-immunity pair Rhs2-SciX from Salmonella Typhimurium.

This work probes the structure and function of the orphan toxin-immunity pair Rhs2-SciX, demonstrates the biochemical diversity of Salmonella T6SS effectors, and highlights the conserved T6SS toxicity strategy of binding EF-Tu.

N. Cobo, S. Goyal, David E. Davidson et al. · 0 citations
Oct 2026

Minimal Functional Scaffolds of the Streptococcus sinensis Competence-Stimulating Peptide Define the Balance between Receptor Promiscuity and Signaling Specificity.

Quorum sensing (QS) enables bacteria to coordinate collective behaviors through the detection of secreted signaling molecules and represents an attractive target for anti-virulence therapeutic development. In Streptococcus sinensis, an emerging opportunistic pathogen associated with infective endocarditis, QS is mediat...

Clay P. Renshaw, Angela Wang, Christopher R. Yeh et al. · 0 citations
Open access Aug 2026

Receptor-binding domain 2 of Clostridioides difficile binary toxin as a promising vaccine component against C. difficile infection

Symptoms of Clostridioides difficile infection (CDI) are primarily caused by two major protein toxins, toxin A (TcdA) and toxin B (TcdB). In addition, approximately 5-30% of C. difficile strains produce a third toxin, C. difficile binary toxin (CDT), which is has been associated with enhanced virulence and severe disea...

Shaohui Wang, Joshua Heuler, Yukihiro Nakanishi et al. · 0 citations
Open access Aug 2026

Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects

It is demonstrated that nanobodies targeting the PLpro/ISG15 interface can achieve synergistic antiviral and immunomodulatory effects, providing a proof-of-concept for a novel therapeutic approach to combat SARS-CoV-2 and potentially other emerging coronaviruses.

Guo-Long Liu, Jian-Tao Chen, Fang Wu et al. · 0 citations
Open access Sep 2026

Molecular mechanism of complement interference by Streptococcus pyogenes nuclease A

Bacteria deploy virulence factors to subvert host immunity; yet the molecular details of these interactions often remain limited. Here, we reveal the structure and host interactome of the Streptococcus pyogenes nuclease A (SpnA). We characterize the structure and dynamics of SpnA using hydrogen-deuterium exchange mass...

Isabella A. Bennig, Joel Ströbaek, R. Mamede et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.